Medscape7h
5-Year TAVR, Surgery Outcomes Similar in Low-risk Patients
Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...
Medical Device Network on MSN1d
Medtronic reports late-breaking data from TAVR system trial for aortic stenosis
Medtronic has reported late-breaking data from the randomised Evolut Low Risk Trial’s five-year outcomes of the Evolut transcatheter aortic valve replacement (TAVR) system in low-risk aortic stenosis ...
American Hospital Association2d
FDA recalls Medtronic Aortic Root Cannulas
The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of ...
New transcatheter valve safe, effective for treating aortic regurgitation
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...